Utah Medical Products UTMD EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Utah Medical Products’s reported figures.
Based on trailing twelve months.
The official record: Utah Medical Products’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Utah Medical Products's EBITDA margin?
- Utah Medical Products (UTMD) reported EBITDA margin of 36.6% in Q1 2026.
- How has Utah Medical Products's EBITDA margin changed year-over-year?
- Utah Medical Products's EBITDA margin decreased by 8.5% year-over-year, from 40% to 36.6%.
- What is the long-term trend for Utah Medical Products's EBITDA margin?
- Over 5 years (2020 to 2025), Utah Medical Products's EBITDA margin has grown at a -5.5% compound annual growth rate (CAGR), from 49.5% to 37.3%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.